Amphetamines, Serum or Plasma, Quantitative
Also known as: AMPS SP
Use
This test is used to detect exposure to amphetamines in a patient. It can identify the presence and quantify levels of various amphetamines in serum or plasma. The drugs covered include amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA), with the cutoff concentrations for each being 20 ng/mL.
Special Instructions
Not provided.
Limitations
The absence of expected drugs or drug metabolites can result from non-compliance, improper timing of specimen collection related to drug administration, inadequate drug absorption, or the inherent limitations of testing. The concentration value must meet or exceed the cutoff for it to be reported as positive. Hemolyzed specimens, plasma or whole blood collected in lt. blue (sodium citrate), and specimens exposed to repeated freeze/thaw cycles are unacceptable.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 30112-7 - Amphet SerPl-mCnc
- 3778-8 - Methamphet SerPl-mCnc
- 59837-5 - MDA SerPl-mCnc
- 18356-6 - MDMA SerPl-mCnc
- 33016-7 - MDEA SerPl-mCnc
Result Turnaround Time
1-8 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate serum from cells ASAP or within 2 hours of collection. Transfer to an ARUP Standard Transport Tube.
Storage Instructions
Refrigerated.
Causes for Rejection
Separator tubes; plasma or whole blood collected in lt. blue (sodium citrate); specimens exposed to repeated freeze/thaw cycles; hemolyzed specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 2 weeks |
| Frozen | 3 years |
Other tests from different labs that may be relevant